Half Of Ozempic Weight-Loss Users Drop The Drug Within A Year

Key Takeaways

Half of people taking semaglutide for weight loss drop it within a year

The cost of the medication appears to be a leading reason for people quitting the drug, researchers say

GLP-1 drugs must be taken long-term to have a lasting benefit

MONDAY, Sept. 15, 2025 (HealthDay News) — Half of people who start taking the GLP-1 weight-loss drug Ozempic drop it within a year, a new study says.

About 52% of people in Denmark prescribed semaglutide (Ozempic, Wegovy ) for weight loss stopped taking it after one year, researchers reported Saturday at a meeting of the European Association for the Study of Diabetes in Vienna.

The drugs’ high cost appears to be the reason why people give them only a brief try, researchers said.

“This level of drop off is concerning because these m